![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 26, 19620-19627, June 30, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Department of Medicinal Chemistry and Pharmacognosy,
University of Illinois, Chicago, Illinois 60607-7173
Received for publication, February 17, 2000, and in revised form, April 18, 2000
The activity of Hsp70 proteins is regulated by
accessory proteins, among which the most studied are the members of the
DnaJ-like protein family. BiP/GRP78 chaperones the translocation and
maturation of secreted and membrane proteins in the endoplasmic
reticulum. No DnaJ-like partner has been described so far to regulate
the function of mammalian BiP/GRP78. We show here that murine BiP/GRP78 interacts with the lumenal J domain of the murine transmembrane protein
MTJ1 (J-MTJ1). J-MTJ1 stimulates the ATPase activity of BiP/GRP78 at
stoichiometric concentrations. The C-terminal tail of BiP/GRP78 is not
required for the interaction with J-MTJ1, leaving the function of this
portion of the molecule still unclear. Physical interactions between
J-MTJ1 and BiP/GRP78 are stable and can be abolished by a single
histidine The molecular chaperone BiP/GRP78, a member of the HSP70 family,
is involved in many cellular processes, including regulation of calcium
homeostasis (1, 2), translocation of newly synthesized polypeptides
across the endoplasmic reticulum membrane (3-5), and their subsequent
folding, maturation, transport or retrotranslocation (6, 7). BiP and
other Hsp70 proteins consist of two domains: the 44-kDa N-terminal
domain, which carries a weak ATPase activity (8, 9), and a C-terminal
domain, which consists of a 20-kDa peptide-binding subdomain followed
by a highly helical and variable 10-kDa C-terminal tail (10, 11).
Although a C-terminal regulatory motif has been identified as important
for the activity of the cytosolic Hsp70 (12), the function of the
C-terminal tail of other Hsp70 proteins is still unknown.
Hsp70 proteins are regulated through the coupling of the ATPase
activity of the N-terminal domain with the binding and release of
unfolded polypeptides by the C-terminal domain (13). ATP binding onto
the N-terminal domain leads to a low affinity state for unfolded
peptides, characterized by fast exchange rates for the substrate
(14-17). ATP hydrolysis induces change in the Hsp70 conformation that
leads to the high affinity state, characterized by a slow off-rate of
the peptidic substrate (14). It is believed that this cycle prevents
the irreversible aggregation of polypeptides and promotes an overall
more efficient folding process (18).
BiP/GRP78, and other Hsp70 proteins, self-associate into multiple
oligomeric species (19-23). The C-terminal domain of BiP/GRP78 has
been shown to be solely responsible for the oligomeric properties of
the protein (22, 24). Binding of unfolded peptidic substrate onto the
C-terminal domain, or binding of ATP onto the N-terminal domain,
promotes depolymerization and stabilization of BiP monomers (21, 22,
24). The level of BiP basal ATPase activity varies with the degree of
BiP oligomerization: the more oligomeric BiP is, the less active it is
(21). Synthetic peptides that exhibit high affinity for BiP/GRP78 are
also the most efficient in stimulating its catalytic activity and in
stabilizing monomeric species (24).
The weak basal ATPase activity of Hsp70 proteins, with a turnover rate
of about 0.02-0.5 min An interaction of mammalian BiP with an endoplasmic reticulum-resident
DnaJ homologue has not been characterized yet. The murine protein MTJ1
has been identified as a putative membrane DnaJ-like protein enriched
in the microsomal and nuclear fractions of murine cells (39). We
investigated whether MTJ1 constitutes an accessory protein able to
regulate murine BiP/GRP78 catalytic activity. We present here
biochemical evidence that the J domain of MTJ1
(J-MTJ1)1 interacts with
murine BiP/GRP78 and stimulates its ATPase activity, and that the
interaction between BiP/GRP78 and MTJ1 is mediated by an invariant
motif found in all DnaJ-like proteins. J-MTJ1 can also activate the
activity of the E. coli DnaK, although at higher
concentrations. However, the E. coli DnaJ does not interact with murine BiP/GRP78.
Plasmids--
pHis6-BiP was engineered from pT7B115
(21). The sequence coding for mature mouse BiP was amplified by
polymerase chain reaction (PCR) with Pfu polymerase (Stratagene,
La Jolla, CA) using the forward primer
5'-CCGCTCGAGGAGGAGGACAAGAAGGAG-3' and the reverse primer
5'CCCAAGCTTTAATGCGGTAGTTTATC-3'. The PCR product was then digested with XhoI and HindIII enzymes (sites are
underlined in the primers) and ligated into the pET15b vector (Novagen,
Madison, WI) with T4 DNA ligase (MBI Fermentas, Amherst, NY). This
vector allows expression of a six-histidine tag followed by a thrombin cleavage site (LVP(R/G)S) at the N-terminal extremity of the protein. The plasmid pHis6-BiP.ent was obtained from pFLAG-BiP.ent
(22), by following the same strategy. The plasmid
His10-BiP-ent-C19 encodes for a truncated form of BiP
(residues 1-550) and will be described
elsewhere.2 The plasmid
pHis6-J-MTJ1 encodes the lumenal domain of MTJ1, from the
start of the J domain following the first transmembrane segment, to the
beginning of the second potential transmembrane segment (residues
46-148). The sequence coding for MTJ1 was amplified from a cDNA
clone kindly provided by Dr. B. Zetter (Harvard Medical School, Boston,
MA). After PCR amplification with Pfu polymerase using the forward
primer Nde-MTJ1, 5'-GGGAATTCCATATGAGCGGAGACCTGGAGTTGTTC-3', and the reverse primer Bam-MTJ1,
5'-GCGGATCCCTAAGCATTGCTCATTTTTCTCACTC-3', the PCR product
was digested with NdeI and BamHI enzymes (sites are underlined in the primers) and subcloned into pET15b. The plasmid
pHis6-Jo-MTJ1 codes for the J domain only of
MTJ1 (residues 46-129). The coding sequence of the J domain was
amplified using the forward primer Nde-MTJ1 described above and the
reverse primer, 5'-CGGGATCCCTAAAGTCCATTGATCAGAAC-3'. The
PCR product was then digested with NdeI and BamHI
enzymes and ligated into pET15b. The coding sequence of DnaJ was
amplified from the plasmid pRLM232 (40), a kind gift of Dr. R. McMacken
(Johns Hopkins University, Baltimore, MD), and subcloned into pET15b,
in-frame with the hexahistidine N-terminal tag and the thrombin site.
Site-directed Mutagenesis--
Site-directed mutagenesis was
performed using two rounds of PCR in a procedure adapted from Morrison
and Desrosiers (41). In the first set of reactions, the partial 5' and
3' fragments of J-MTJ1:H89Q were amplified from the pJ-MTJ1 plasmid
with the Nde-MTJ1 and the Bam-MTJ1 outside primers, and the
5'-GCTTTCACTAACCTTACAACCAGACAAGAATAAAG-3' and
5'-CTTTATTCTTGTCTGGTTGTAAGGTTAGTGAAAGC-3'
overlapping inside primers, which encode the H89Q mutation
(underlined in the primers). The PCR products were gel-purified using
low melting point agarose as described previously (42), mixed in
equimolar concentrations, and used as templates for the second round of PCR amplification, together with the Nde-MTJ1 and the Bam-MTJ1 outside
primers described above. The final product was digested with
NdeI and BamHI enzymes and ligated into pET15b.
The presence of the mutation was confirmed by DNA sequencing by using
the Fentomol kit (Promega, Madison, WI) or the Sequenase kit (U. S.
Biochemical Corp., Cleveland, OH).
Protein Expression and Purification--
The recombinant
proteins were expressed in E. coli BL21(DE3) cells. The
cells were grown at 37 °C until A600 ~ 0.6, and synthesis of recombinant proteins was induced by addition of
isopropyl-1-thio- Far-UV Circular Dichroism Spectra--
Circular dichroism (CD)
spectra were obtained on a spectrometer (model 710, Jasco, Easton, MD).
Spectra of native BiP (10 µM) were obtained in assay
buffer. Spectra of native J-MTJ1 (11 µM) and mutant
J-MTJ1:H89Q (8 µM) were obtained in 10 mM
sodium phosphate, pH 7.0. Far-UV CD experiments were carried out at
room temperature in the wavelength region of 250-190 nm with a 0.1-cm path length cell. Data were recorded at 0.5-nm intervals with a time
constant of 1.0 s and a 1.0-nm constant spectral bandwidth. Data
were averaged over five repetitive scans and fitted for protein concentration and optical path length. The mean residue ellipticity ( ATPase Assays--
Concentration-dependent assays
were carried out as described (49). Time-dependent assays
were done as follows: 70 µl of total assay buffer supplemented with
100 µM ATP, 1 µCi of [ BiP-MTJ1 Binding Assays--
His6-BiP (10 µg) in
20 mM Hepes, pH 7.0, 75 mM KCl, 5 mM MgCl2, 0.1% Tween 20, 2% glycerol, 1 mM phenylmethylsulfonyl fluoride (buffer B) was mixed with
20 µg of cleaved wild-type or mutant form of J-MTJ1, in the absence
or presence of 1 mM ATP or ADP. After incubation at
37 °C for 30 min, 50 µl of the metal-chelating resin (50%
suspension) was added and the samples were further incubated at 4 °C
for 30 min, with gentle shaking. The resin was then washed five times
with ice-cold buffer B, and the bound complexes were eluted by boiling
after addition of SDS-PAGE sample buffer. Following denaturation, the
samples were loaded onto a 15% SDS gel. After electrophoretic
migration, the gels were stained with Coomassie blue and the quantity
of proteins was estimated by densitometry scanning of the gel (1D
analysis, Eastman Kodak, Rochester, NY). The data were then normalized
to an equivalent background value.
Sequence Analysis of MTJ1--
The in situ topology and
cellular localization of MTJ1 has not been investigated yet. Using the
most recent software available, we re-analyzed the primary sequence of
MTJ1 and re-examined its putative topology (Figs.
1 and 2).
An N-terminal signal sequence containing a putative cleavage site
between amino acids 43 and 44, and a KKXX-like retrieval
signal present near the C terminus, could account for MTJ1 retention in
the endoplasmic reticulum (50). The N-terminal portion of MTJ1 carries
a conserved J domain of about 70 amino acids (residues 60-117) that
displays 42% identity with the J domain of yeast Sec63p. The J domain
would be followed by one (model one, preferred model) or two (model
two) putative transmembrane domains, exposing the C-terminal domain to
the cytosolic or the luminal side, respectively (Fig. 2). In both
models, the J domain of MTJ1 would be exposed in the lumen of the
endoplasmic reticulum, similar to that of Sec63p (51), as proposed
originally by Zetter and coworkers (39). Interestingly, another stretch of amino acids (residues 408-463) exhibits homology with Sec63p with
28% identity throughout this small region. This Sec63-homologous region is surrounded by two stretches of amino acids (residues 324-375
and residues 491-543) reminiscent of tryptophan-mediated repeats, also
called the SANT domains, found in other DnaJ-like proteins such as
MIDA-1, a murine protein involved in cell growth (52, 53), the
Zuotin-related factors (54-56), the proto-oncogene c-myb (57-59), and the M-phase phosphoprotein 11 (60).
Expression of J-MTJ1--
The lumenal domain of MTJ1 (residues
46-148) that encompasses the J domain was expressed in E. coli as a hexahistidine-tagged protein and found to be soluble and
monomeric. After purification on a metal-chelating affinity column, the
N-terminal histidine tag was removed by digestion with thrombin. The
cleavage was fast and efficient, with a yield superior to 95% after
4 h of proteolytic digestion (Fig.
3, top panel). Cleaved J-MTJ1
was then submitted to far-UV CD spectroscopy (Fig. 3, bottom left
panel). The spectra of wild-type J-MTJ1 presents the
characteristic features of helical proteins: a high maximum at 195 nm
followed by two minima at 208 and 222 nm. Deconvolution of the spectrum
indicates that J-MTJ1 contains about 75% helical structures. These
results demonstrate that wild-type MTJ1 is folded into a mostly helical
domain, in agreement with the solution structure of the J domains of
the E. coli DnaJ (61-63) and of the human HDJ1 (64).
Steady-state ATPase Stimulation of BiP by
J-MTJ1--
His6-BiP was purified by affinity
chromatography followed by ion exchange chromatography on MonoQ HR 5/5
(Amersham Pharmacia Biotech). His6-BiP is fully active in
ATPase assays, and the kinetic parameters obtained in steady-state
conditions are of the same order of magnitude as values determined for
BiP purified from other constructs (Table
I). His6-BiP purified in
these conditions was found to be mostly monomeric (data not shown),
contrary to our previously described His10-BiP that has a
high tendency to oligomerize (22), and exhibits a slightly lower basal
ATPase activity (Table I). Large variations in the basal ATPase
activity of His10-BiP preparations correlate with the
extent of aggregation/polymerization: lower activities were observed
for highly polymerized samples, and higher activities were obtained for
mostly monomeric samples. Single turnover experiments conducted with
His6-BiP indicate that the rate of ATP hydrolysis
(k2 ~ 0.30 min The J Domain Is Only Sufficient to Stimulate BiP/GRP78
Activity--
The fragment J-MTJ1 corresponds to the putative luminal
domain, most of which corresponds to the Sec63-like J domain (Fig. 1).
However, the C-terminal region of J-MTJ1 contains one tryptophan (Trp-132), one phenylalanine (Phe-137), and two tyrosines (Tyr-138 and
Tyr-139), residues that are highly enriched in peptides that bind to
BiP with high affinity (24, 65, 66). To ensure that such an interaction
was not taking place here, we expressed and assayed the J domain only
(Jo-MTJ1, residues 46-129) for its ability to stimulate
BiP ATPase activity. The fragment Jo-MTJ1 (0.4 µM) stimulates 2-fold the activity of
His6-BiP (0.2 µM), with a
kcat value of 0.47 min Effect of J-MTJ1 on BiP-ent and BiP-ent-C19--
We have described
earlier the engineering of a FLAG-BiP-ent protein, in which the N- and
C-terminal domains are linked by an enterokinase site and showed that
FLAG-BiP-ent displays a slightly higher basal ATPase activity than
His10-BiP and was slightly stimulated by a specific
unfolded peptide, i.e. Pep2 (LSVKFLT) (22). We proposed that
the insertion of one extra residue in the hinge between the two domains
somehow disengaged the two domains from each other, therefore
alleviating the inhibitory effect of the C terminus on the N-terminal
catalytic domain (22). However, FLAG-BiP-ent had a high tendency to
oligomerize and aggregate (22). We replaced the N-terminal FLAG epitope
by a hexahistidine or decahistidine tag and assayed whether
His6-BiP-ent and His10-BiP-ent could be
efficiently stimulated by millimolar concentrations of a synthetic
peptide and by submicromolar concentrations of J-MTJ1. As observed
previously, the insertion of the enterokinase site slightly increased
the basal activity of BiP (Table I). Interestingly, the peptide Pep2
does not efficiently stimulate BiP-ent (Table I), most likely because
the purified BiP-ent proteins are enriched in monomeric species and the
peptide binding does not cause further monomerization and apparent
stimulation of BiP ATPase activity. When His6-BiP-ent (0.2 µM) was incubated in the presence of a 2-fold molar
excess of J-MTJ1, its ATPase activity was stimulated by a factor of
1.65 (Table I). In similar conditions, His10-BiP-ent was
stimulated by J-MTJ1 by a factor of 2 (Table I). The stoichiometry of
BiP:J-MTJ1 interaction, and the action of J-MTJ1 on BiP-ent, a mostly
monomeric protein that is not efficiently stimulated by millimolar
concentrations of peptide, indicates that the J-MTJ1 stimulation of BiP
ATPase activity is distinct from the peptide-induced stimulation caused
by monomerization of inactive oligomers (22, 24).
The C-terminal domain of Hsp70 proteins is actually composed of two
subdomains: A J-MTJ1 Physically Interacts with BiP--
Next, we studied the
physical interaction between BiP and the J domain of MTJ1. We used a
binding assay in which His6-BiP and wild-type J-MTJ1 were
incubated in the absence, or presence, of adenosine nucleotides and
then immobilized onto a metal-chelating nickel resin. The unbound
material was washed away, and the bound proteins were analyzed by
SDS-PAGE. Our data indicate that His6-BiP and J-MTJ1 can
form stable complexes in all conditions (Fig.
5, left panels).
Mutation in the Conserved HPD Sequence Abolishes BiP:MTJ1
Interaction--
From bacteria to high eukaryotes, all DnaJ-like
proteins share a conserved HPD motif, whose integrity is essential for
interaction with their Hsp70 partner, as demonstrated in E. coli (69), in yeast (32, 70) and human (71). We have expressed and
purified a mutant form of J-MTJ1 in which the conserved histidine
residue (in bold in Fig. 1) was substituted by a glutamine
(J-MTJ1:H89Q). Circular dichroism analysis in the far-UV region shows
that the mutant protein folds into a structure similar to that of
wild-type J-MTJ1 (Fig. 3, bottom right panel). Deconvolution
of the spectrum indicates that the mutant J-MTJ1:H89Q contains about
80% of helical structures, a value close to the 75% obtained for the
wild-type protein. The mutant J-MTJ1:H89Q does not stimulate
His10-BiP ATPase activity (Fig. 4, open circles)
and does not interact with His6-BiP (Fig. 5, right
panels). This indicates that the single substitution in the
conserved HPD motif of J-MTJ1 totally abolishes interactions with
murine BiP.
J-MTJ1 Stimulates Efficiently the E. coli DnaK, But the E. coli
DnaJ Does Not Stimulate BiP Activity--
Hsp70 proteins are not
interchangeable in yeast (72, 73), and the efficiency of stimulation of
ATPase activity in yeast Hsp70 proteins is most efficient in the
presence of the genuine DnaJ-like partner (34, 74). These observations
suggest that J-MTJ1 would not efficiently stimulate the ATPase activity
of a foreign Hsp70. To investigate this hypothesis, we tested whether the E. coli Hsp70, i.e. DnaK, could be stimulated
by J-MTJ1. Surprisingly, J-MTJ1, but not the mutant J-MTJ1:H89Q,
stimulates the basal ATPase activity of DnaK by a factor of 8 (Fig.
6A and Table I). The double
reciprocal plot (Fig. 6B) allows graphic determination of an
apparent affinity equal to 1.17 µM for 0.3 µM DnaK: thus J-MTJ1 stimulates DnaK activity but with an
apparent affinity that is at least four times lower than the one
obtained for BiP. It should be noted that the basal activity of
unstimulated DnaK (kcat = 0.05 min
We next assayed whether the full-length E. coli DnaJ could
stimulate BiP as well as its genuine partner DnaK. Fig.
7 clearly shows that DnaJ stimulates DnaK
at substoichiometric concentrations (0.12 µM DnaJ for 0.3 µM DnaK) but has no effect on BiP activity (Fig. 7,
open circles).
We report here the characterization of the interaction of murine
BiP with the luminal domain of the murine DnaJ-like protein MTJ1.
Several years ago, MTJ1 was identified as a putative transmembrane protein enriched in the heavy microsomal and nuclear fractions (39).
MTJ1 is widely expressed in all tissues, but its function has not been
investigated. Re-examination of the MTJ1 amino acid sequence allowed us
to propose two models for its topology. Both models place the J domain
of MTJ1 in the lumen of the endoplasmic reticulum, consistent with the
lumenal localization of the J domain of the yeast Sec63p (51). This
makes MTJ1 a potential partner for the molecular chaperone BiP/GRP78.
The predicted topology of the C-terminal domain is less obvious,
because the MTJ1 sequence may contain one or two additional putative
transmembrane domains. The C-terminal domain does not have any homology
with other known proteins, except for two DNA binding domains
homologous to SANT domains (or Trp-repeat domain) found in two other
DnaJ-like proteins, MIDA1 and the zuotin-related factor ZRF1, but also
in the proto-oncogene c-myb and the M-phase phosphoprotein
11 and related genes. These domains are thought to be involved in
substrate binding (52-59) and may represent the site of interaction
between MTJ1 and potential partners. Interestingly, the C-terminal
domain of the E. coli DnaJ and of the yeast Ydj1p also
contain a zinc finger-like domain (75-77). It has been proposed that
the zinc finger domain of DnaJ is able to form a hydrophobic pocket in
which unfolded peptidic substrates bind before being further delivered
to the peptide binding pocket of the molecular chaperone DnaK (75). We
are currently testing if the C-terminal domain of MTJ1 can bind
unfolded polypeptides.
The J domain of MTJ1 (J-MTJ1) was successfully expressed in E. coli and found to fold in a mostly Several pieces of evidence indicate that MTJ1 interacts with BiP/GRP78
in a native manner that is distinct from the interactions of the BiP C
terminus with unfolded peptides (24, 65). First, CD spectroscopy gave
us a good indication that J-MTJ1 was folded and, therefore, would not
interact with BiP as an unfolded substrate. Second, BiP is stimulated
up to almost 5-fold by stoichiometric concentrations of J-MTJ1 (J-MTJ1,
Km = 0.31 µM for 0.3 µM
BiP) but is stimulated 2- to 3-fold by much higher concentrations of
short synthetic peptides used as models for denatured substrates (peptide, Km = 5-100 µM) (Table I and
Refs. 22, 24). Third, a form of BiP that contains an engineered
enterokinase site between the N-terminal catalytic domain and the
peptide binding domain is stimulated about 2-fold by submicromolar
concentrations of J-MTJ1 but is only slightly stimulated by millimolar
concentrations of Pep2 (1.15- to 1.2-fold stimulation, Table I).
Therefore, the insertion of one residue to create the enterokinase site
at the junction between the two domains does not alter the ATPase stimulation by the J domain as much as it affects the coupling between
the peptide binding and the catalytic domains. One explanation is that
J-MTJ1 may bind to a conserved channel present in the catalytic domain,
as described for DnaJ interaction with DnaK (79), and that the
interaction is not being totally impaired by the insertion of one amino
acid in the hinge region. Other studies, however, showed that insertion
or four or more amino acids impairs the DnaJ:DnaK interaction (27) and
that DnaJ binding enables coupling between the catalytic domain
and the peptide binding domain of DnaK (79). Taken together, these
findings suggest that DnaJ-like proteins interact strongly with the
catalytic domain of Hsp70 proteins through their conserved J domain but may also make contact with the peptide binding domain.
Finally, the integrity of the highly conserved HPD motif is essential
for BiP:J-MTJ1 physical interactions and for J-MTJ1-stimulated ATPase
activity of BiP. BiP/GRP78 peptide binding domain recognizes specifically stretches of amino residues rich in large and/or aromatic
hydrophobic amino acids (24, 66) and totally excludes charged residues
such as histidine or aspartate found in the HPD motif. This strongly
indicates that BiP/GRP78 binds to unfolded polypeptides and to J-MTJ1
through different type of interactions.
Our results also demonstrate that the C-terminal tail of BiP is not
necessary for BiP:J-MTJ1 interaction. This is in agreement with studies
on the rat RDJ1 J domain and the 60-kDa proteolytic fragment of Hsc70
(68) and with studies showing that a truncated form of DnaK is
efficiently stimulated by DnaJ (79). Apart from the regulatory role of
the EEVD motif present at the C terminus of Hsp70 (12), the C-terminal
tail of BiP and of other Hsp70 proteins has not been shown to be
involved in any cellular mechanism, and its function remains obscure.
We show that BiP and J-MTJ1 are able to interact physically. This is
consistent with the results obtained by Brodsky and coworkers (34) on
the J domain of Sec63p with yeast BiP/kar2p and of Ungewickell and
co-workers (37, 38) that demonstrate that the J domain of auxilin
interacts with Hsc70. However, studies on DnaJ indicate that the
glycine/phenylalanine-rich region linking the J domain to the
C-terminal domain is essential for interaction with DnaK (69). The
E. coli DnaJ belongs to class I of DnaJ-like proteins, but
auxilin, MTJ1, Sec63, and its newly identified human homologue (80) all
belong to class III (81). It appears that class III DnaJ-like proteins
may not require elements other than the J domain to regulate the
activity of their Hsp70 partner. The J domain of MTJ1 and Sec63p is
exposed in the lumen of the endoplasmic reticulum. It is reasonable to
think that, for transmembrane DnaJ-like proteins like Sec63 and MTJ1,
the J domain alone is sufficient to recruit their Hsp70 counterpart
near the translocation channel where it can perform its function.
We do not observe that the physical interaction between BiP and J-MTJ1
requires a high concentration of ATP, contrary to what has been
observed for Sec63p or auxilin (32, 34, 38). Because our studies were
performed on nucleotide-free BiP (see "Experimental Procedures"),
this may represent a specific feature of murine BiP and/or J-MTJ1. BiP
self-associates into multiple oligomeric species (21), and ATP binding
induces rapid monomerization (22). The His6-BiP used in the
present study has a lower tendency to self-associate than the
His10-BiP previously described and was isolated as a mostly
monomeric species. The requirement for ATP may not be necessary,
because His6-BiP is already in a fully monomeric conformation.
The J domain of MTJ1 stimulates very efficiently the E. coli
DnaK (Table I), although a 3- to 4-fold molar excess is required to
reach the Vmax level (J-MTJ1,
Km = 1.17 µM for 0.3 µM
DnaK), indicating that J-MTJ1 has a lower affinity for DnaK than for
the murine BiP/GRP78 (Table I). Interestingly, full-length DnaJ does
not stimulate BiP activity, even when present at a 7-fold molar excess
(Fig. 7). It seems that the J domain of MTJ1 has been extremely
conserved throughout evolution and can still stimulate DnaK, but the
domains adjacent to the J domain in DnaJ prevent its interaction with
the murine BiP/GRP78. We conclude that the J domain can be sufficient
for interaction with an Hsp70 partner despite its origin and
localization, but other structural determinants may play an important
role in the specificity and stability of the complex. Our data are
consistent with other studies that showed that J domains can be
substituted by others and still lead to a functional DnaJ homologue
(82, 83). Some slight modification in the sequence of the J domain may,
however, be necessary to restore fully functional activity in
vivo, as demonstrated in yeast (84).
The newly characterized MTJ1 may prove to be a genuine partner for
BiP/GRP78. Further studies on the cellular localization and topology of
MTJ1 and the role of its C-terminal domain are currently in progress.
This should help improve the understanding of the function of murine
BiP and MTJ1 in the endoplasmic reticulum of mammalian cells.
We are very grateful to Dr. Bruce Zetter
(Harvard Medical School, Boston, MA) for sending us the MTJ1 clone and
to Dr. Roger McMacken (Johns Hopkins University, Baltimore, MD) for
supplying DnaK, DnaJ, and GrpE overexpressing strains as well as very
detailed protocols and plasmid maps. We thank Mary Hall for purifying
DnaK, Sunghyouk Park for his help in the deconvolution of circular
dichroism spectra, and LaShaunda King and Michael Berg for critical
reading of the manuscript.
*
This work was supported in part by National Institutes of
Health Grant GM58107 (to S. Y. B.).The costs of publication of this article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
To whom correspondence should be addressed: Center for
Pharmaceutical Biotechnology (M/C 870), College of Pharmacy, Dept. of
Medicinal Chemistry and Pharmacognosy, Molecular Biology Research Bldg., University of Illinois, 900 S. Ashland Ave., Chicago, IL 60607-7173. Tel.: 312-996-5416; Fax: 312-413-9303; E-mail:
blond@uic.edu.
Published, JBC Papers in Press, April 20, 2000, DOI 10.1074/jbc.M001333200
2
L. King, M-G. Berg, C. Wang, A. Carey, M. Chevalier, E. C. Elguindi, and S. Y. Blond, manuscript in preparation.
3
M. Chevalier, unpublished data.
The abbreviations used are:
J-MTJ1, J domain of
protein MTJ1;
PCR, polymerase chain reaction;
PAGE, polyacrylamide gel
electrophoresis;
CD, circular dichroism.
Interaction of Murine BiP/GRP78 with the DnaJ Homologue MTJ1*
, and
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
glutamine substitution in the highly conserved HPD motif
shared by all DnaJ-like proteins. The J-MTJ1 fragment, but not the
mutant J-MTJ1:H89Q fragment, stimulates the ATPase activity of
Escherichia coli DnaK, although at a higher concentration
than its genuine partner DnaJ. Full-length DnaJ does not stimulate BiP
over the range of concentrations investigated. These results indicate
that the J domain of MTJ1 is sufficient for its interaction with
BiP/GRP78 and cannot be substituted by E. coli DnaJ.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1, is too slow to account by itself
for the rate of assisted protein folding (13, 14). In Escherichia
coli, two accessory proteins, DnaJ and GrpE, are essential for the
chaperone functions of DnaK (25, 26). DnaJ specifically activates the
ATP hydrolysis step of the reaction (27), and GrpE is a
nucleotide-exchange factor that increases the rate of release of ADP
(28). It has been demonstrated that, acting together, these two
proteins can stimulate the steady-state ATPase activity of DnaK by 20- to 200-fold (17, 25, 29, 30). In yeast, the DnaJ-like transmembrane
protein Sec63p is essential for the translocation process during which it interacts with Kar2p, the yeast homologue of BiP/GRP78 (31-33). The
interaction between Sec63p and BiP/Kar2p is mediated by the conserved J
domain, located near the N terminus of Sec63p (32, 34, 35). Similarly,
the mammalian cytosolic DnaJ-like protein auxilin, which plays an
important role in the dissociation of clathrin vesicles (36), stably
interacts with the uncoating ATPase Hsc70 through its C-terminal J
domain (37, 38).
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-D-galactopyranoside (Fischer
Scientific, Hanover Park, IL) at 0.4 mM final
concentration. Cells were harvested after 1-h induction for the
different BiP proteins and after 2-h induction for J-MTJ1 or
Jo-MTJ1 expressing cultures. Histidine-tagged proteins were
purified on cobalt-chelating resin (Talon resin,
CLONTECH, Palo Alto, CA). After binding to the
resin in 20 mM Tris base, pH 8.0, 100 mM NaCl
(buffer A), and a wash of nonspecific protein with 5 mM
imidazole in buffer A, the bound proteins were eluted with 50 and 100 mM imidazole in buffer A. Eluted fractions were dialyzed
overnight at 4 °C in 20 mM Tris base, pH 8.0, 50 mM KCl, 5 mM MgCl2 and loaded onto a MonoQ 5/5 HR anion exchange column connected to a fast protein liquid
chromatography system (Amersham Pharmacia Biotech). Bound proteins were
then eluted with a linear gradient of KCl (50-200 mM).
Fractions were analyzed by SDS-polyacrylamide gel electrophoresis (PAGE) as described (43). Nucleotide-free BiP proteins were prepared as
described (44). Briefly, purified BiP was mixed with activated charcoal
(1 mg/ml) in 10 mM Na2EDTA, pH 8.0. After incubation for 4 h at 4 °C, the sample was centrifuged and the supernatant dialyzed exhaustively against 20 mM Hepes, pH
7.0, 75 mM KCl, 5 mM MgCl2 (assay
buffer). Contamination by nucleotides was evaluated
spectrophotometrically. An
A280/A260 ratio of >1.5 indicated that the sample were free of nucleotides (45). For removal of
the hexahistidine N-terminal tag, His6-J-MTJ1 or
His6-DnaJ (30 µg) was incubated with 0.1 unit of thrombin
(Sigma) at room temperature for 4 h. The cleaved proteins were
then collected in the flow-through fraction of a Talon column. When
necessary, the MTJ1-derived proteins were further purified by gel
filtration on Superdex 75 (Pharmacia Amersham Biotech), equilibrated in
assay buffer. All proteins were transferred into the assay buffer prior to analysis. Protein concentrations were estimated by the method of
Bradford (46) or spectrophotometrically measured by using the
extinction coefficients at 280 nm calculated by the method of Gill and
von Hippel (47), i.e. 26,860 M
1
cm
1 and 13,730 M
1
cm
1 for BiP and J-MTJ1, respectively. E. coli
DnaK was expressed from the plasmid pRLM163, a kind gift of Dr. R. McMacken and purified as described (48).
) was calculated by using a mean residue weight of 110.9 and expressed in deg.cm2/dmol per residue. Data were analyzed
by the spectral deconvolution method JFIT provided by Dr. B. Rupp
(Lawrence Livermore National Laboratory, Livermore, CA).
-32P]ATP
(Amersham Pharmacia Biotech, 3000 mmol/Ci), and 0.2-0.3 µM BiP or DnaK was incubated at 37 °C with 0.4-0.6
µM J-MTJ1 protein. At various time points, 10 µl of the
reaction mixtures was retrieved and quenched in SDS at 1% final
concentration. The samples were then processed by thin layer
chromatography or direct quantification of a phosphomolybdate complex
as described (49). For assays in single turnover conditions, BiP (1 to
2 µM) was incubated with 10-30 nM ATP and
0.05 µCi of [
32P]ATP, in 20 mM Hepes, pH
7.0, 5 mM MgCl2, and 75 mM KCl or
50 mM NaCl. After incubation at 37 °C, 10-µl aliquots
were quenched with 2 µl of 1 N HCl and put on ice. Conversion of ATP
into ADP was determined by thin layer chromatography as described
(49).
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (45K):
[in a new window]
Fig. 1.
Analysis of MTJ1 amino acid sequence (Swiss
Protein Data Base accession number Q61712). The transmembrane
domains (long dashed underline) were predicted by using the
TMPRED program. The signal peptide (dotted line) and
cleavage site (arrow) were predicted with the program
SignalP v1.1 (85). The DnaJ-like domain (triple underline)
and the SANT domains (bold plain underline) were predicted
by using the SMART program (86). The second region that presents
homology with the yeast Sec63p (small dashed underline) has
been identified using the alignment program SIM. The C-terminal
endoplasmic reticulum retrieval signal (thick dotted line)
was identified with the program PSORT II.

View larger version (27K):
[in a new window]
Fig. 2.
Potential topology of murine MTJ1 and yeast
Sec63p. A, two models can be proposed for MTJ1 topology
(see "Results"). B, the topology proposed by Feldheim
and coworkers for Sec63p (51) is consistent with recent data obtained
for a human homologue (80).

View larger version (22K):
[in a new window]
Fig. 3.
Purification and characterization of the J
domain of MTJ1. Top panel, 15% SDS-PAGE analysis of
His6-J-MTJ1 before and after cleavage by thrombin.
Lane 1, uncleaved His6-J-MTJ1; lane
2, cleaved J-MTJ1; lane 3, purified cleaved J-MTJ1 not
retained by the metal-chelating resin. Bottom panel, far-UV
CD spectra of J-MTJ1 wild-type (left panel) and J-MTJ1:H89Q
mutant (right panel). The protein concentrations were 11 and
8 µM for the wild-type and the mutant, respectively, in
10 mM sodium phosphate, pH 7.0. The open
circles, the closed circles, and the closed
triangles represent the experimental data, the fitted data (as
calculated by the JFIT method), and the difference between experimental
and fitted data, respectively.
1, data not shown)
is similar to the steady-state value (kcat ~ 0.34 min
1), indicating that the rate of ATP hydrolysis is
the rate-limiting step in BiP activity. J-MTJ1 causes a 2-fold
stimulation of the steady-state ATPase activity of His6-BiP
when used at a concentration as low as two molar excess over BiP (Table
I). Because His10-BiP has a lower basal activity than
His6-BiP (Table I), we investigated whether J-MTJ1 can
stimulate His10-BiP ATPase activity more efficiently. Concentration dependence experiments show that the steady-state ATPase
activity of His10-BiP is indeed stimulated by a 4- to
5-fold factor at a saturating concentration of J-MTJ1 (Fig.
4A). From the
double-reciprocal plot (Fig. 4B), we calculated that the
apparent affinity constant of J-MTJ1 for 0.3 µM BiP is
equal to a Km value for MTJ1 of 0.31 µM. Thus, the J domain of MTJ1 stimulates efficiently the
ATPase activity of BiP/GRP78 at stoichiometric concentrations.
Catalytic constants determined in steady-state conditions for BiP and
DnaK in the presence of a synthetic peptide or J-MTJ1

View larger version (14K):
[in a new window]
Fig. 4.
Concentration-dependent
stimulation of BiP ATPase activity by J-MTJ1. A,
stimulation of His10-BiP steady-state ATPase activity by
increasing concentrations of wild-type J-MTJ1 and mutant J-MTJ1:H89Q.
His10-BiP (0.2 µM) was incubated with
increasing concentrations (0.03-10 µM) of wild-type
J-MTJ1 (closed circles) or mutant J-MTJ1:H89Q (open
circles) and assayed for ATPase activity as described under
"Experimental Procedures." B, double reciprocal plot of
BiP ATPase activity stimulated by J-MTJ1.
1
versus kcat = 0.27 min
1
for the unstimulated BiP (data not shown).
-sandwich of 18-19 kDa that is responsible for the
binding of unfolded peptidic substrates and a 10- to 11-kDa C-terminal
helical tail of still unknown function (10, 67). Some observations
indicate that the C-terminal tail of Hsp70 is involved in the
regulation of Hsp70 ATPase activity as well as its chaperone function
(12). To determine whether that region was important for BiP:MTJ1
interactions, we engineered a 60-kDa BiP-ent protein (residues 1-550,
BiP-ent-C19) in which part of the C-terminal tail was deleted. Within
experimental errors, His10-BiP-ent and
His10-BiP-C19 have comparable basal and Pep2-stimulated
activities (Table I). Both proteins are stimulated as efficiently
by submicromolar concentrations of J-MTJ1 (Table I). This
indicates that the C-terminal tail of BiP is not necessary for ATPase
stimulation by the J domain, in agreement with other studies on Hsc70
and RDJ1 (68).

View larger version (48K):
[in a new window]
Fig. 5.
Complex formation between BiP and
J-MTJ1. Interaction of His6-BiP with J-MTJ1
(left panels) or J-MTJ1:H89Q (right panels) was
assayed as described under "Experimental
Procedures." Top panels, Coomassie-stained 15%
SDS-PAGE. Lane 1, His6-BiP; lane 2;
cleaved J-MTJ1 (or, right panel, mutant J-MTJ1:H89Q);
lane 3, His6-BiP with wild-type J-MTJ1 (or,
right panel, mutant J-MTJ1:H89Q); lane 4,
His6-BiP with wild-type (or, right panel, mutant
J-MTJ1:H89Q) in the presence of 1 mM ATP; lane
5, His6-BiP with wild-type (or, right
panel, mutant J-MTJ1:H89Q) in the presence of 1 mM
ADP. Bottom panel, densitometry scanning of the SDS-PAGE.
The y axis represents the average of three independent
experiments.
1) is much lower than the kcat
obtained for any of the BiP used in the present and previous studies
(kcat = 0.2-0.5 min
1, Table I and
Refs. 21, 24, and 49). J-MTJ1 stimulates DnaK activity by a factor of
8, so even stimulated DnaK functions at a rate that is at least 2-fold
slower than that of BiP.

View larger version (12K):
[in a new window]
Fig. 6.
Effect of J-MTJ1 and J-MTJ1:H89Q on DnaK
ATPase activity. A, steady-state stimulation of DnaK
activity by J-MTJ1 or J-MTJ1:H89Q. DnaK (0.3 µM) was
incubated with increasing concentrations (0.03-10 µM) of
wild-type J-MTJ1 (closed circles) or J-MTJ1:H89Q (open
circles) and assayed for ATPase activity. B, double
reciprocal plot of J-MTJ1 stimulated ATPase activity of DnaK.

View larger version (13K):
[in a new window]
Fig. 7.
Effect of DnaJ on DnaK and BiP ATPase
activity. A, steady-state stimulation of DnaK and BiP
activity by DnaJ. 0.3 µM DnaK (closed circles)
or His10-BiP (open circles) was incubated with
increasing concentrations of DnaJ and assayed for ATPase activity.
B, double reciprocal plot of DnaJ-stimulated ATPase activity
of DnaK.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-helical conformation, as
observed for the J domains of the bacterial DnaJ (63) and of the human
HDJ1 (64). Interaction with equimolar concentrations of J-MTJ1 led to
the stimulation of the basal ATPase activity of BiP/GRP78 up to 5-fold.
Single turnover experiments indicated that J-MTJ1 enhances the rate of
ATP hydrolysis in the BiP catalytic cycle,3 in agreement with
recent kinetic studies on DnaK:DnaJ interaction (27, 78).
![]()
ACKNOWLEDGEMENTS
![]()
FOOTNOTES
Supported by a grant from the Talaat Basha Family Foundation.
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1.
Lievremont, J. P.,
Rizzuto, R.,
Hendershot, L.,
and Meldolesi, J.
(1997)
J. Biol. Chem.
272,
30873-30879
2.
Hamman, B. D.,
Hendershot, L. M.,
and Johnson, A. E.
(1998)
Cell
92,
747-758
3.
Brodsky, J. L.,
Goeckeler, J.,
and Schekman, R.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
9643-9646
4.
Corsi, A. K.,
and Schekman, R.
(1996)
J. Biol. Chem.
271,
30299-30302
5.
Lyman, S. K.,
and Schekman, R.
(1997)
Cell
88,
85-96
6.
Hammond, C.,
and Helenius, A.
(1995)
Curr. Opin. Cell Biol.
7,
523-529
7.
Brodsky, J. L.,
Werner, E. D.,
Dubas, M. E.,
Goeckeler, J. L.,
Kruse, K. B.,
and McCracken, A. A.
(1999)
J. Biol. Chem.
274,
3453-3460
8.
Chappell, T. G.,
Konforti, B. B.,
Schmid, S. L.,
and Rothman, J. E.
(1987)
J. Biol. Chem.
262,
746-751
9.
Flaherty, K. M.,
DeLuca-Flaherty, C.,
and McKay, D.
(1990)
Nature
346,
623-628
10.
Zhu, X.,
Zhao, X.,
Burkholder, W. F.,
Gragerov, A.,
Ogata, C. M.,
Gottesman, M. E.,
and Hendrickson, W. A.
(1996)
Science
272,
1606-1614
11.
Wang, H.,
Kurochkin, A. V.,
Pang, Y.,
Hu, W.,
Flynn, G. C.,
and Zuiderweg, E. R.
(1998)
Biochemistry
37,
7929-7940
12.
Freeman, B. C.,
Myers, M. P.,
Schumacher, R.,
and Morimoto, R. I.
(1995)
EMBO J.
14,
2281-2292
13.
Bukau, B.,
and Horwich, A. L.
(1998)
Cell
92,
351-366
14.
Schmid, D.,
Baici, A.,
Gehring, H.,
and Christen, P.
(1994)
Science
263,
971-973
15.
McCarty, J. S.,
Buchberger, A.,
Reinstein, J.,
and Bukau, B.
(1995)
J. Mol. Biol.
1249,
126-137
16.
Theyssen, H.,
Schuster, H. P.,
Packschies, L.,
Bukau, B.,
and Reinstein, J.
(1996)
J. Mol. Biol.
263,
657-670
17.
Pierpaoli, E. V.,
Sandmeier, E.,
Baici, A.,
Schonfeld, H. J.,
Gisler, S.,
and Christen, P.
(1997)
J. Mol. Biol.
269,
757-768
18.
Fedorov, A. N.,
and Baldwin, T. O.
(1997)
J. Biol. Chem.
272,
32715-32718
19.
Freiden, P. J.,
Gaut, J. R.,
and Hendershot, L. M.
(1992)
EMBO J.
11,
63-70
20.
Carlino, A.,
Toledo, H.,
Skaleris, D.,
DeLisio, R.,
Weissbach, H.,
and Brot, N.
(1992)
Proc. Natl. Acad. Sci. U. S. A.
89,
2081-2085
21.
Blond-Elguindi, S.,
Fourie, A. M.,
Sambrook, J. F.,
and Gething, M.-J.
(1993)
J. Biol. Chem.
268,
12730-12735
22.
Chevalier, M.,
King, L.,
Wang, C.,
Gething, M. J.,
Elguindi, E.,
and Blond, S. Y.
(1998)
J. Biol. Chem.
273,
26827-26835
23.
Fouchaq, B.,
Benaroudj, N.,
Ebel, C.,
and Ladjimi, M. M.
(1999)
Eur. J. Biochem.
259,
379-384
24.
King, L.,
Chevalier, M.,
and Blond, S. Y.
(1999)
Biochem. Biophys. Res. Commun.
263,
181-186
25.
Liberek, K.,
Marszalek, J.,
Ang, D.,
Georgopoulos, C.,
and Zylicz, M.
(1991)
Proc. Natl. Acad. Sci. U. S. A.
88,
2874-2878
26.
Wickner, S.,
Skowyra, D.,
Hoskins, J.,
and McKenney, K.
(1992)
Proc. Natl. Acad. Sci. U. S. A.
89,
10345-10349
27.
Laufen, T.,
Mayer, M. P.,
Beisel, C.,
Klostermeier, D.,
Mogk, A.,
Reinstein, J.,
and Bukau, B.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
5452-5457
28.
Packschies, L.,
Theyssen, H.,
Buchberger, A.,
Bukau, B.,
Goody, R. S.,
and Reinstein, J.
(1997)
Biochemistry
36,
3417-3422
29.
Gamer, J.,
Multhaup, G.,
Tomoyasu, T.,
McCarty, J. S.,
Rudiger, S.,
Schonfeld, H. J.,
Schirra, C.,
Bujard, H.,
and Bukau, B.
(1996)
EMBO J.
15,
607-617
30.
Banecki, B.,
and Zylicz, M.
(1996)
J. Biol. Chem.
271,
6137-6143
31.
Scidmore, M. A.,
Okamura, H. H.,
and Rose, M. D.
(1993)
Mol. Biol. Cell
4,
1145-1159
32.
Corsi, A. K.,
and Schekman, R.
(1997)
J. Cell Biol.
137,
1483-1493
33.
Matlack, K. E.,
Misselwitz, B.,
Plath, K.,
and Rapoport, T. A.
(1999)
Cell
97,
553-564
34.
McClellan, A. J.,
Endres, J. B.,
Vogel, J. P.,
Palazzi, D.,
Rose, M. D.,
and Brodsky, J. L.
(1998)
Mol. Biol. Cell
9,
3533-3545
35.
Misselwitz, B.,
Staeck, O.,
Matlack, K. E.,
and Rapoport, T. A.
(1999)
J. Biol. Chem.
274,
20110-20115
36.
Ungewickell, E.,
Ungewickell, H.,
Holstein, S. E. H.,
Lindner, R.,
Prasad, K.,
Barouch, W.,
Martin, B.,
Greene, L. E.,
and Eisenberg, E.
(1995)
Nature
378,
632-635
37.
Holstein, S. E.,
Ungewickell, H.,
and Ungewickell, E.
(1996)
J. Cell Biol.
135,
925-937
38.
Ungewickell, E.,
Ungewickell, H.,
and Holstein, S. E.
(1997)
J. Biol. Chem.
272,
19594-19600
39.
Brightman, S. E.,
Blatch, G. L.,
and Zetter, B. R.
(1995)
Gene
153,
249-254
40.
Karzai, A. W.,
and McMacken, R.
(1996)
J. Biol. Chem.
271,
11236-11246
41.
Morrison, H. G.,
and Desrosiers, R. C.
(1993)
BioTechniques
14,
454-457
42.
Sambrook, J. F.,
Fritsch, E. F.,
and Maniatis, T.
(1989)
Molecular Cloning: A Laboratory Manual
, 2nd Ed.
, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
43.
Laemmli, U. K.
(1970)
Nature
227,
680-685
44.
Ha, J.,
and McKay, D. B.
(1994)
Biochemistry
33,
14625-14635
45.
Farr, C. D.,
Slepenkov, S. V.,
and Witt, S. N.
(1998)
J. Biol. Chem.
273,
9744-9748
46.
Bradford, M. M.
(1976)
Anal. Biochem.
72,
248-254
47.
Gill, S. C.,
and Hippel, P. H. v.
(1989)
Anal. Biochem.
182,
319-326
48.
Russell, R.,
Jordan, R.,
and McMacken, R.
(1998)
Biochemistry
37,
596-607
49.
Chevalier, M.,
King, L.,
and Blond, S.
(1998)
Methods Enzymol.
290,
384-409
50.
Teasdale, R. D.,
and Jackson, M. R.
(1996)
Annu. Rev. Cell Dev. Biol.
12,
27-54
51.
Feldheim, D.,
Yoshimura, K.,
Admon, A.,
and Schekman, R.
(1993)
Mol. Biol. Cell
4,
931-939
52.
Shoji, W.,
Inoue, T.,
Yamamoto, T.,
and Obinata, M.
(1995)
J. Biol. Chem.
270,
24818-24825
53.
Inoue, T.,
Shoji, W.,
and Obinata, M.
(1999)
Biochem. Biophys. Res. Commun.
266,
147-151
54.
Kanei-Ishii, C.,
Sarai, A.,
Sawazaki, T.,
Nakagoshi, H.,
He, D. N.,
Ogata, K.,
Nishimura, Y.,
and Ishii, S.
(1990)
J. Biol. Chem.
265,
19990-19995
55.
Howe, K. M.,
Reakes, C. F.,
and Watson, R. J.
(1990)
EMBO J.
9,
161-169
56.
Gabrielsen, O. S.,
Sentenac, A.,
and Fromageot, P.
(1991)
Science
253,
1140-1143
57.
Zhang, S.,
Lockshin, C.,
Herbert, A.,
Winter, E.,
and Rich, A.
(1992)
EMBO J.
11,
3787-3796
58.
Yan, W.,
Schilke, B.,
Pfund, C.,
Walter, W.,
Kim, S.,
and Craig, E. A.
(1998)
EMBO J.
17,
4809-4817
59.
Hugues, R.,
Chan, F. Y.,
White, R. A.,
and Zon, L. I.
(1995)
Genomics
29,
546-550
60.
Matsumoto-Taniura, N.,
Pirollet, F.,
Monroe, R.,
Gerace, L.,
and Westendorf, J. M.
(1996)
Mol. Biol. Cell
7,
1455-1469
61.
Hill, R. B.,
Flanagan, J. M.,
and Prestegard, J. H.
(1995)
Biochemistry
34,
5587-5597
62.
Szyperski, T.,
Pellecchia, M.,
Wall, D.,
Georgopuolos, C.,
and Wüthrich, K.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
11343-11347
63.
Pellecchia, M.,
Szyperski, T.,
Wall, D.,
Georgopoulos, C.,
and Wuthrich, K.
(1996)
J. Mol. Biol.
260,
236-250
64.
Qian, Y. Q.,
Patel, D.,
Hartl, F. U.,
and McColl, D. J.
(1996)
J. Mol. Biol.
260,
224-235
65.
Blond-Elguindi, S.,
Cwirla, S. E.,
Dower, W. J.,
Lipshutz, R. J.,
Sprang, S. R.,
Sambrook, J. F.,
and Gething, M. J.
(1993)
Cell
75,
717-728
66.
Fourie, A. M.,
Sambrook, J. F.,
and Gething, M.-J. H.
(1994)
J. Biol. Chem.
269,
30470-30478
67.
Bertelsen, E. B.,
Zhou, H.,
Lowry, D. F.,
Flynn, G. C.,
and Dahlquist, F. W.
(1999)
Protein Sci.
8,
343-354
68.
Leng, C. H.,
Brodsky, J. L.,
and Wang, C.
(1998)
Protein Sci.
7,
1186-1194
69.
Wall, D.,
Zylicz, M.,
and Georgopoulos, C.
(1994)
J. Biol. Chem.
269,
5446-5451
70.
Tsai, J.,
and Douglas, M. G.
(1996)
J. Biol. Chem.
271,
9347-9354
71.
Liu, J. S.,
Kuo, S. R.,
Makhov, A. M.,
Cyr, D. M.,
Griffith, J. D.,
Broker, T. R.,
and Chow, L. T.
(1998)
J. Biol. Chem.
273,
30704-30712
72.
Brodsky, J. L.,
Hamamoto, S.,
Feldheim, D.,
and Schekman, R.
(1993)
J. Cell Biol.
120,
95-102
73.
James, P.,
Pfund, C.,
and Craig, E. A.
(1997)
Science
275,
387-389
74.
Cyr, D. M.,
and Douglas, M. G.
(1994)
J. Biol. Chem.
269,
9798-9804
75.
Szabo, A.,
Korzun, R.,
Hartl, F.-U.,
and Flanagan, J.
(1996)
EMBO J.
15,
408-417
76.
Banecki, B.,
Liberek, K.,
Wall, D.,
Warrzynow, A.,
Georgopoulos, C.,
Bertoli, E.,
Tanfani, F.,
and Zylicz, M.
(1996)
J. Biol. Chem.
271,
14840-14848
77.
Lu, Z.,
and Cyr, D. M.
(1998)
J. Biol. Chem.
273,
5970-5978
78.
Russell, R.,
Wali Karzai, A.,
Mehl, A. F.,
and McMacken, R.
(1999)
Biochemistry
38,
4165-4176
79.
Gassler, C. S.,
Buchberger, A.,
Laufen, T.,
Mayer, M. P.,
Schroder, H.,
Valencia, A.,
and Bukau, B.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
15229-15234
80.
Skowronek, M. H.,
Rotter, M.,
and Haas, I. G.
(1999)
Biol. Chem.
380,
1133-1138
81.
Cheetham, M. E.,
and Caplan, A. J.
(1998)
Cell Stress Chaperones
3,
28-36
82.
Campbell, K. S.,
Mullane, K. P.,
Aksoy, I. A.,
Stubdal, H.,
Zalvide, J.,
Pipas, J. M.,
Silver, P. A.,
Roberts, T. M.,
Schaffhausen, B. S.,
and DeCaprio, J. A.
(1997)
Genes Dev.
11,
1098-1110
83.
Kelley, W. L.,
and Georgopoulos, C.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
3679-3684
84.
Schlenstedt, G.,
Harris, S.,
Risse, B.,
Lill, R.,
and Silver, P.
(1995)
J. Cell Biol.
129,
979-988
85.
Nielsen, H.,
Engelbrecht, J.,
Brunak, S.,
and von Heijne, G.
(1997)
Protein Eng.
10,
1-6
86.
Schultz, J.,
Milpetz, F.,
Bork, P.,
and Ponting, C. P.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
5857-5864
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
M. Yamamoto, D. Maruyama, T. Endo, and S.-i. Nishikawa Arabidopsis thaliana Has a Set of J Proteins in the Endoplasmic Reticulum that are Conserved from Yeast to Animals and Plants Plant Cell Physiol., October 1, 2008; 49(10): 1547 - 1562. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. V. Oskolkova, T. Afonyushkin, A. Leitner, E. von Schlieffen, P. S. Gargalovic, A. J. Lusis, B. R. Binder, and V. N. Bochkov ATF4-dependent transcription is a key mechanism in VEGF up-regulation by oxidized phospholipids: critical role of oxidized sn-2 residues in activation of unfolded protein response Blood, July 15, 2008; 112(2): 330 - 339. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. G. Jakobsen, N. Rasmussen, A.-V. Laenkholm, and H. J. Ditzel Phage Display Derived Human Monoclonal Antibodies Isolated by Binding to the Surface of Live Primary Breast Cancer Cells Recognize GRP78 Cancer Res., October 1, 2007; 67(19): 9507 - 9517. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. N. Hebert and M. Molinari In and Out of the ER: Protein Folding, Quality Control, Degradation, and Related Human Diseases Physiol Rev, October 1, 2007; 87(4): 1377 - 1408. [Abstract] [Full Text] [PDF] |
||||
![]() |
|